doi: 10.3389/fmed.2023.1124275 Received 14 December 2022 Accepted 27 February 2023 Published 22 March 2023 Volume 10 - 2023 Edited by Ana Sandoval-Rodriguez, University of Guadalajara, Mexico Reviewed by Angelo Armandi, University of Turin, Italy
Semaglutide and liraglutide are structurally similar molecules with high selectivity for the GLP-1 receptor, though there are some pharmacologic differences between the two notably, liraglutide has a higher steady state concentration and greater receptor binding affinity than semaglutide, while semaglutide has an increased affinity for serum albumin (thereby improving resistance to degradation) and a longer half-life than liraglutide [38, 61, 62]
Se recomienda aumentar la dosis gradualmente cada 4 semanas segn tolerancia para minimizar efectos secundarios gastrointestinales y optimizar la respuesta teraputica individual
However, if you experience sudden vision loss or other severe symptoms, its important to understand that there could be potential Zepbound vision problems that need immediate attention